Skip Navigation
Menu
Letters |20 November 2018

Omalizumab Rescue Therapy for Refractory Status Asthmaticus

Katrin Milger, MD; Ines Schroeder, MD; Jürgen Behr, MD; Tobias Meis, MD; Werner v. Wulffen, MD, PhD; Nikolaus Kneidinger, MD, PhD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
This article was published at Annals.org on 20 November 2018.
×
FULL TEXT
Background: Despite advances in asthma therapy, asthma mortality has remained stable in recent years (1). One reason is status asthmaticus, which can be unresponsive to initial treatment and may lead to hypercapnic respiratory failure despite maximal therapy.
Objective: To alert clinicians to the possibility of a new rescue option for status asthmaticus.
Case Report: A 41-year-old man developed severe dyspnea while working at an outside construction site. The patient had a history of asthma with pollen allergy. He had not consulted a respiratory physician recently but had been using a short-acting β2-agonist inhaler several times daily for several weeks. The emergency physician who arrived at the site noted severe wheezing and intubated the patient for respiratory failure, and the patient was hospitalized.
FULL TEXT
PDF
Not Available
Citations
Citation

Milger K, Schroeder I, Behr J, Meis T, Wulffen WV, Kneidinger N. Omalizumab Rescue Therapy for Refractory Status Asthmaticus. Ann Intern Med. [Epub ahead of print ]:. doi: 10.7326/L18-0359

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2018.

DOI: 10.7326/L18-0359

©
2018 American College of Physicians
0 Citations

Related Articles
Review: Omalizumab added to corticosteroids reduces exacerbations and corticosteroid use in adults and children with asthma
Annals of Internal Medicine; 154 (10): JC5-11
Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy: A Randomized Trial
Annals of Internal Medicine; 154 (9): 573-582
Omalizumab Therapy for Patients With Severe Asthma
Annals of Internal Medicine; 154 (9): I-28
Hypophosphatemia Complicating Management of Acute Severe Asthma
Annals of Internal Medicine; 112 (1): 68-69
View MoreView Less

Journal Club
Review: Omalizumab added to corticosteroids reduces exacerbations and corticosteroid use in adults and children with asthma
Annals of Internal Medicine; 154 (10): JC5-11
View MoreView Less

Related Topics
Asthma
Pulmonary/Critical Care

Asthma, Pulmonary/Critical Care.

PubMed Articles
Pharmacological advances in pemphigoid.
Curr Opin Pharmacol 2019;
Short- and long-term real-world effectiveness of omalizumab in severe allergic asthma: systematic review of 42 studies published 2008-2018.
Expert Rev Clin Immunol 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×